| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/26/2009 | CN100531794C Compositions and methods for modifying toxic effects of protein compounds |
| 08/25/2009 | US7579448 Adding to the microbial fermentation broth or homogenate, a solution of 6,9-diamino-2-ethoxyacridine lactate (ethacridine lactate) to precipitate host cell impurities, polypeptide remains soluble, separating the desiered polypeptide |
| 08/25/2009 | US7579447 Antibodies against LLG polypeptides of the triacylglycerol lipase family |
| 08/25/2009 | US7579446 Rabies virus G protein specific immunoglobulin for use in prevention and treatment of viral infections |
| 08/25/2009 | US7579445 Reagents and methods for inducing an immune response to prostate specific antigen |
| 08/25/2009 | US7579329 P450RAI-2 (P450 cytochrome 26B), encoding nucleic acid molecules and methods and uses thereof |
| 08/25/2009 | US7579316 Compositions and methods to modulate an immune response to an immunogenic therapeutic agent |
| 08/25/2009 | US7579187 Anti-A33 antibody |
| 08/25/2009 | US7579186 Human monoclonal antibody against TGF-β type II receptor and medicinal use thereof |
| 08/25/2009 | US7579173 Targeted glycosaminoglycan polymers by polymer grafting and methods of making and using the same |
| 08/25/2009 | US7579170 Method for preparing monoclonal antibodies capable of activating effector cells expressing FCγRIII |
| 08/25/2009 | US7579169 producing a mutant HH polypeptide by transforming isolated host cells with a vector capable of expressing the polypeptide from the nucleic acid sequence; diagnosis, prenatal screening and diagnosis, and therapies of blood disorders |
| 08/25/2009 | US7579160 Cervical Cancer; Using monoclonal antibody comprising immunostimulant domains to diagnose and treat cell proliferative disorders; binding; lung tumor polypeptides, immunogenic portions, polynucleotides that encode such polypeptides, antigen presenting , T cells that are specific; |
| 08/25/2009 | US7579157 Antibody selection method against IGF-IR |
| 08/25/2009 | US7579007 Production of “biological carriers” for induction of immune responses and inhibition of viral replication |
| 08/25/2009 | US7579002 Method for improving body weight uniformity and increasing carcass yield in animals |
| 08/25/2009 | US7579001 Antagonists of TWEAK and of TWEAK receptor and their use to treat immunological disorders |
| 08/25/2009 | US7578999 Antibodies specific for sclerostin |
| 08/25/2009 | CA2395539C Soluble interleukin-20 receptor |
| 08/25/2009 | CA2385302C Receptor proteins specifically recognizing bacterial dna |
| 08/25/2009 | CA2088889C Specific antibodies against activated platelets, the preparation thereof and the use thereof in diagnosis and therapy |
| 08/20/2009 | WO2009101968A1 Anti-adam-15 antibodies and utilization of the same |
| 08/20/2009 | WO2009101611A1 Monoclonal antibodies for tumor treatment |
| 08/20/2009 | WO2009101059A2 Methods of using cadherin 11 (cdh11) antagonists |
| 08/20/2009 | WO2009100942A1 Ligands of the natural killer (nk) cell surface marker cd27 and therapeutic uses thereof |
| 08/20/2009 | WO2009081069A3 Polyclonal antibody directed against the elastin binding protein and method for obtaining same |
| 08/20/2009 | WO2009079242A3 Aglycosylated immunoglobulin mutants |
| 08/20/2009 | WO2009070294A3 Inhibition of macrophage-stimulating protein receptor (ron) and methods of treatment thereof |
| 08/20/2009 | WO2009056631A3 Molecules and methods for modulating complement component |
| 08/20/2009 | WO2009053604A3 Influenza virus haemagglutinin-specific monoclonal antibodies |
| 08/20/2009 | WO2009038760A3 Human gm-csf antigen binding proteins |
| 08/20/2009 | WO2007021841A9 Identification and engineering of antibodies with variant fc regions and methods of using same |
| 08/20/2009 | US20090210966 rice blast susceptibility gene pi21, resistance gene pi21 and uses thereof |
| 08/20/2009 | US20090210954 Genes |
| 08/20/2009 | US20090210951 Avian transgenesis using an ovalbumin nucleotide sequence |
| 08/20/2009 | US20090209734 Peptidyl prodrugs and linkers and stabilizers useful therefor |
| 08/20/2009 | US20090209733 Therapeutic agent for rheumatoid arthritis |
| 08/20/2009 | US20090209732 Secreted and Transmembrane Polypeptides and Nucleic Acids Encoding the Same |
| 08/20/2009 | US20090209466 Peptides with anti-proliferative activity |
| 08/20/2009 | US20090209464 inhibiting Flavivirus infection by inhibiting the fusion between the virion envelope and a cell membrane; E1 envelope glycoprotein of hepaciviruses and E2 envelope glycoprotein of pestivirus have previously undescribed structures, truncated class II fusion proteins |
| 08/20/2009 | US20090209045 Screening assay |
| 08/20/2009 | US20090209034 Tumour rejection antigens |
| 08/20/2009 | US20090209006 Taci-immunoglobulin fusion proteins |
| 08/20/2009 | US20090209004 Human il-1 beta antagonists |
| 08/20/2009 | US20090208982 Assay method for human orotate phosphoribosyltransferase protein |
| 08/20/2009 | US20090208972 Cytotoxic protein and utlization thereof |
| 08/20/2009 | US20090208969 Polynucleotides and Polypeptides Encoding Receptors |
| 08/20/2009 | US20090208949 Phosphatidylinositol phosphate kinase type i gamma splice variants as biomarkers and drug targets for epithelial cancers |
| 08/20/2009 | US20090208938 Use of the MCM8 Gene for the Preparation of a Pharmaceutical Composition |
| 08/20/2009 | US20090208522 Neutralizing Epitope-Based Growth Enhancing Vaccine |
| 08/20/2009 | US20090208514 Method of diagnosing esophageal cancer |
| 08/20/2009 | US20090208512 Catalytic anti-factor VIII allo-antibodies |
| 08/20/2009 | US20090208510 Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins |
| 08/20/2009 | US20090208507 Protein isoforms and uses thereof |
| 08/20/2009 | US20090208506 Antibodies against flagellin and uses thereof |
| 08/20/2009 | US20090208504 Polypeptides involved in immune response |
| 08/20/2009 | US20090208503 Immunotherapeutic treatment |
| 08/20/2009 | US20090208502 Apoptosis-inducing protein complexes and therapeutic use thereof |
| 08/20/2009 | US20090208501 Anti-Pathogen Immunoadhesins |
| 08/20/2009 | US20090208498 Genetic Products Differentially Expressed In Tumors And The Use Thereof |
| 08/20/2009 | US20090208497 Humanized anti-cd4 antibody with immunosuppressive properties |
| 08/20/2009 | US20090208496 Humanized anti-cd4 antibody with immunosuppressive properties |
| 08/20/2009 | US20090208494 Humanized antibody molecules specific for il-31 |
| 08/20/2009 | US20090208491 Compositions and Methods for Diagnosing and Treating Cancer |
| 08/20/2009 | US20090208489 Antibodies That Bind OV064 and Methods of Use Therefor |
| 08/20/2009 | US20090208487 Prevention and treatment of synucleinopathic and amyloidogenic disease |
| 08/20/2009 | US20090208486 Pharmaceutical composition comprising cxcr3 inhibitor |
| 08/20/2009 | US20090208483 Antibody selective for dr4 and uses thereof |
| 08/20/2009 | US20090208451 Halogen phosphonate monoesters |
| 08/20/2009 | US20090208418 Superantibody synthesis and use in detection, prevention and treatment of disease |
| 08/20/2009 | US20090208416 Monoclonal antibodies against nkg2a |
| 08/20/2009 | US20090208411 Cytotoxicity mediation of cells evidencing surface expression of CD44 |
| 08/20/2009 | CA2715166A1 Monoclonal antibodies for tumor treatment |
| 08/20/2009 | CA2714657A1 Anti-adam-15 antibodies and utilization of the same |
| 08/20/2009 | CA2711499A1 Vaccines and diagnostics for the ehrlichioses |
| 08/20/2009 | CA2689680A1 Fc receptor-binding polypeptides with modified effector functions |
| 08/19/2009 | EP2090662A2 Process for the production of a fine chemical |
| 08/19/2009 | EP2090657A2 Anti-IL-12 antibodies, compositions, methods and uses |
| 08/19/2009 | EP2090656A1 Mutant androgen receptor, cancer cells expressing the same, method of constructing the same and use thereof |
| 08/19/2009 | EP2090591A2 Antibodies, recombinant antibodies, recombinant antibody fragments and fusions mediated plant disease resistance against fungi |
| 08/19/2009 | EP2090590A1 Antibody against aflatoxins, support using the antibody, method of immunologically detecting aflatoxins and method of concentrating and purifying aflatoxins |
| 08/19/2009 | EP2090320A1 Ligands of the Natural Killer (NK) cell surface marker CD27 and therapeutic uses thereof |
| 08/19/2009 | EP2089722A1 Biomarkers |
| 08/19/2009 | EP2089514A1 Cancerous disease modifying antibodies |
| 08/19/2009 | EP2089434A1 Anti-idiotype conjugate and its use as a standard in an immunassay |
| 08/19/2009 | EP2089433A2 Therapy targeting cathepsin s |
| 08/19/2009 | EP2089432A1 Anti-glycoprotein vi scfv fragment for treatment of thrombosis |
| 08/19/2009 | EP2089431A2 Methods and compositions for efficient removal of protein a from binding molecule preparations |
| 08/19/2009 | EP2089430A1 Selection of human monoclonal antibodies by mammalian cell display |
| 08/19/2009 | EP2089429A2 Process for preparing unaggregated antibody fc domains |
| 08/19/2009 | EP2089428A2 Crystalline anti-htnfalpha antibodies |
| 08/19/2009 | EP2089411A2 Compositions and methods to treat cancer with cupredoxins and cpg rich dna |
| 08/19/2009 | EP2089061A1 Inhibition of sox9 function fn the treatment of proteogl ycan-associated pathophysiological conditions |
| 08/19/2009 | EP2089057A2 Methods and compositions for treating and monitoring treatment of il-13-associated disorders |
| 08/19/2009 | EP2088997A1 Liquid anti-rabies antibody formulations |
| 08/19/2009 | EP1497467B1 Oligonucleotides from sequences coding for the surface component of ptlv envelope proteins and uses thereof |
| 08/19/2009 | EP1482973B1 Methods of modulating cd200 receptors |
| 08/19/2009 | EP1463529B1 Ph-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
| 08/19/2009 | EP1290181B1 Method for modifying plant morphology, biochemistry and physiology |
| 08/19/2009 | EP1255829B1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |